Hostname: page-component-848d4c4894-r5zm4 Total loading time: 0 Render date: 2024-06-15T11:07:28.124Z Has data issue: false hasContentIssue false
  • English
  • Français

Risperidone induced neutropenia in a 75-year-old man

Published online by Cambridge University Press:  01 September 2022

D. Nistor ,
L. Horosan  and
A. Giurgiuca
D. Nistor*
Affiliation:
“Prof. Dr. Al. Obregia” Psychiatry Hospital, General Psychiatry, Bucharest, Romania
L. Horosan
Affiliation:
“Prof. Dr. Al. Obregia” Psychiatry Hospital, General Psychiatry, Bucharest, Romania
A. Giurgiuca
Affiliation:
“Prof. Dr. Al. Obregia” Psychiatry Hospital, General Psychiatry, Bucharest, Romania University of Medicine and Pharmacy Carol Davila, Neuroscience 6, Bucharest, Romania
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

We discuss the case of a 75-year-old man with no psychiatric history, presenting with complex auditory hallucinations, both commentary and imperative, delusions of persecution and prejudice, severe anxiety, modified behaviour, and altered sleep patterns.

Objectives

The patient was started on oral risperidone, with favourable evolution of symptoms after reaching a daily dose of 3 mg/day. After three weeks of treatment, the laboratory results showed a low number of neutrophils. Interdisciplinary approach and examinations which included both clinical and paraclinical evaluation concluded that another cause of neutropenia was highly unlikely.

Methods

The patient was switched to olanzapine, with gradually increasing doses up to 10 mg/day. A significant improvement of the neutrophils’ level was noticed, with a return to normal parameters after a few days. Nevertheless, the clinical course was unfavourable, with reoccurrence of auditory hallucinations and delusions in two weeks’ time. Decision to rechallenge was made, with careful monitoring of the blood test results, particularly neutrophil levels. Risperidone was started at low doses of 0.5 mg/day and gradually increased up to 2 mg/day.

Results

Seven days after risperidone reinitiation laboratory tests showed normal absolute neutrophil count. However, another week later, neutrophils fell again out of the normal range.

Conclusions

The patient was discharged with haloperidol, with adequate control of symptoms and no adverse reactions.

Disclosure

No significant relationships.

Keywords

AntipsychoticsneutropeniarisperidoneSide effects
Type
Abstract
Information
European Psychiatry , Volume 65 , Special Issue S1: Abstracts of the 30th European Congress of Psychiatry , June 2022 , pp. S724
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.